Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 891-900

  Aranha, Olivia ^a   Wood Jr , David P ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CASPASE 3; CIPROFLOXACIN; CISPLATIN; CYCLIN B; CYCLIN E; DOXORUBICIN; MITOMYCIN C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; THIOTEPA;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER INHIBITION; CANCER RECURRENCE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; GENE CONTROL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSITIONAL CELL CARCINOMA;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, TRANSITIONAL CELL; CDC2-CDC28 KINASES; CELL CYCLE; CELL DIVISION; CIPROFLOXACIN; CYCLIN B; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; G2 PHASE; GENE EXPRESSION REGULATION; HUMANS; MITOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; S PHASE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0034061756     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wingo, P. A., and Ries, L. A. G. Annual report to the nation on status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst., 91: 675-690, 1999.
2. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
3. Lamm, D. L. Superficial bladder cancer. Urol. Clin. N. Am., 19: 19-25, 1992.
4. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., and Hawkins, I. R. Superficial bladder cancer: progression and recurrence. J. Urol., 13: 1083-1086, 1983.
5. Pauwels, R. P., Schapers, R. F., Smeets, A. W., Debruyne, F. M., and Geraedts, J. P. Grading in superficial bladder cancer. Br. J. Urol., 61: 129-134, 1988.
6. See, W. A., Miller, J. S., and Williams, R. D. Pathophysiology of transitional tumor cell adherence to sites of urothelial injury in rats: mechanisms mediating intravesical recurrence due to implantation. Cancer Res., 49: 5414-5418, 1989.
7. Seay, T. M., Peretsman, S. J., and Dixon, P. S. Inhibition of human transitional cell carcinoma in vitro cell proliferation by fluroquinolone antibiotics. J. Urol., 155: 757-762, 1996.
8. Thrasher, J. B., and Crawford, E. D. Complications of intravesical chemotherapy. Urol. Clin. N. Am., 19: 529-539, 1995.
9. Hollister, D., Jr., and Coleman, M. Hematological effects of intravesicular thiotepa therapy for bladder carcinoma. J. Am. Med. Assoc., 244: 2065-2067, 1980.
10. Lamm, D. L. Complications of bacillus Calmette-Guérin immunotherapy. Urol. Clin. N. Am., 19: 565-572, 1992.
11. Hussy, P., Maass, G., Tummler, B., Grosse, F., and Schomburg, U. Effect of fluroquinolones and novobiocin on calf thymus DNA polymerase α primase complex, topoisomerase I and II and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother., 29: 1073-1078, 1986.
12. Chen, Y. A., and Liu, L. F. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol., 34: 191-218, 1994.
13. Lovislo, J. A. J., Vio, P., Benevenuti, C., and Bono, A. Possible effect of intravenous perioperative perfloxacin on recurrence rate and disease free interval in patients with superficial bladder cancer. J. Urol., 157: 214, 1997.
14. Philipott, N. J., Turner, A. J., Scopes, J., Westby, M., Marsh, J. C., Gordon-Smith, E. C., Dalgleish, A. G., and Gibson, F. M. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum application compared with other techniques. Blood, 87: 2244-2251, 1996.
15. Enari, M., Hug, H., and Nagata, S. Involvement of ICE-like protease in Fas mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
16. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Slavesen, G. S., and Dixit, V. M. Yama/CPP32, a mammalian homologue of ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
17. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
18. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Garren, Y., Gareau, Y., Griffin, P. R., Labelle, M., and Lazebnik, Y. A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
19. Minshul, J., Pines, J., Golstein, R., Standart, N., Mackie, S., Colman, A., Blow, J., Ruderamn, J. V., Wu, M., and Hunt, T. The role of cyclin synthesis, modification and destruction in the control of cell division. J. Cell Sci. (Washington DC), 12: 77-97, 1989.
20. Draetta, G., and Beach, D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell, 54: 17-26, 1988.
21. Dulic, V., Lees, E., and Reed, S. I. Association of human cyclin E, with a periodic G1-S phase protein kinase. Science (Washington DC). 257: 1958-1969, 1992.
22. Suzuki, A., Tsutomi, Y., Akahane, K., Araki, T., and Miura, M. Resistance to Fas mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21 WAF1 and IAP gene family ILP. Oncogene, 17: 931-939, 1998.
23. Bossy-Wetzel, E., Newmeyer, D. D., and Green, D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J., 17: 37-49, 1997.
24. Li, X. S., Rishi, A. K., Shao, Z. M., Dawson, M. I., Jong, L., Shroot, B., Reichert, U., Ordonez, J., and Fontana, J. A. Posttranslational regulation of p21 WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res., 56: 5055-5062, 1996.
25. Clarke, A. S., Lotz, M. M., Chao, C., and Mercurio, A. M. Activation of the p21 pathway of growth arrest and apoptosis by the β4 integrin cytoplasmic domain. J. Biol. Chem., 270: 22673-22676, 1995.
26. Sheikh, M. S., Rochefort, H., and Garcia, M. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene, 11: 1899-1905, 1995.
27. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., and Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
28. Zhang, Y., Fujita, N., and Tsuruo, T. Caspase-mediated cleavage of p21WAF1/CIP1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 18: 1131-1135, 1999.
29. Miclau, T., Edin, M. L., Lester, G. E., Lindsey, R. W., and Dahners, L. E. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J. Orthop. Res., 16: 509-512, 1998.
30. Somekh, E., Douer, D., Shaked, N., and Rubinstein, E. In vitro effects of ciprofloxacin and perfloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines. J. Pharmacol. Exp. Ther., 248: 415-418, 1989.
31. Ebisuno, S., Inagaki, T., Kohjimoto, Y., and Ohkawa, T. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro. Cancer (Phila.), 80: 2263-2267, 1997.
32. Green, D. R., and Reed, J. G. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
33. cdc2/cyclin B. Cancer Res., 52: 1823-1829, 1992.
34. Glotzer, M., Murray, A. W., and Kirschner, M. W. Cyclin is degraded by the ubiquitin pathway. Nature (Lond.), 349: 132-138, 1991.
35. Bisonette, N., and Hunting, D. J. P21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene, 16: 3461-3469, 1998.
36. Donato, J. N., and Perez, M. Tumor necrosis factor induced apoptosis stimulates p53 accumulation and p21 WAF1 proteolysis in ME-180 cells. J. Biol. Chem., 275: 5067-5072, 1998.
37. Jiang, Y., and Porter, A. G. Prevention of tumor necrosis factor (TNF)-mediated induction of p21 WAF1/CIP1 sensitizes MCF7 carcinoma cells to TNF-induced apoptosis. Biochem. Biophys. Res. Commun., 245: 691-697, 1998.
38. Van den Bos, C., Silverstetter, S., Murphy, M., and Connolly, T. p21(cip1) rescues human mesenchymal stem cells from apoptosis induced by low-density culture. Cell Tissue Res., 293: 463-470, 1998.
39. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., and Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
40. Park, J. A., Kim, K. W., Kim, S. I., and Lee, S. K. Caspase 3 specifically cleaves p21 waf1/cip1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur. J. Biochem., 257: 242-248, 1998.
41. Suzuki, A., Tsutomi, Y, Akahane, K., Araki, T., and Miura, M. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene, 18: 1239-244, 1999.
42. Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., and Ross, R. Cleavage of p21 CIP1/WAF1 and p27 Kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of a caspase cascade. Mol. Cell, 1: 553-567, 1998.
43. Hershko, A. Ubiquitin-dependent protein degradation. Annu. Rev. Biochem., 30: 405-439, 1996.
44. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draeta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.